aTYR PHARMA INC (ATYR) Pre-Tax Margin
Complete source-backed pre-tax margin history.
- Available history
- 2019-12-31 to 2025-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -39012.11% |
| 2024-12-31 | -27243.40% |
| 2023-12-31 | -14276.20% |
| 2022-12-31 | -436.55% |
| 2020-12-31 | -155.24% |
| 2019-12-31 | -5631.04% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |